BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 25457201)

  • 1. Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis.
    de Tayrac M; Roth MP; Jouanolle AM; Coppin H; le Gac G; Piperno A; Férec C; Pelucchi S; Scotet V; Bardou-Jacquet E; Ropert M; Bouvet R; Génin E; Mosser J; Deugnier Y
    J Hepatol; 2015 Mar; 62(3):664-72. PubMed ID: 25457201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis.
    Stickel F; Buch S; Zoller H; Hultcrantz R; Gallati S; Österreicher C; Finkenstedt A; Stadlmayr A; Aigner E; Sahinbegovic E; Sarrazin C; Schafmayer C; Braun F; Erhart W; Nothnagel M; Lerch MM; Mayerle J; Völzke H; Schaller A; Kratzer W; Boehm BO; Sipos B; D'Amato M; Torkvist L; Stal P; Arlt A; Franke A; Becker T; Krawczak M; Zwerina J; Berg T; Hinrichsen H; Krones E; Dejaco C; Strasser M; Datz C; Hampe J
    Hum Mol Genet; 2014 Jul; 23(14):3883-90. PubMed ID: 24556216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels.
    Benyamin B; McRae AF; Zhu G; Gordon S; Henders AK; Palotie A; Peltonen L; Martin NG; Montgomery GW; Whitfield JB; Visscher PM
    Am J Hum Genet; 2009 Jan; 84(1):60-5. PubMed ID: 19084217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients.
    Pelucchi S; Mariani R; Calza S; Fracanzani AL; Modignani GL; Bertola F; Busti F; Trombini P; Fraquelli M; Forni GL; Girelli D; Fargion S; Specchia C; Piperno A
    Haematologica; 2012 Dec; 97(12):1818-25. PubMed ID: 22773607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common SNP near BMP2 is associated with severity of the iron burden in HFE p.C282Y homozygous patients: a follow-up study.
    Milet J; Le Gac G; Scotet V; Gourlaouen I; Thèze C; Mosser J; Bourgain C; Deugnier Y; Férec C
    Blood Cells Mol Dis; 2010 Jan; 44(1):34-7. PubMed ID: 19879168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low serum transferrin levels in HFE C282Y homozygous subjects are associated with low CD8(+) T lymphocyte numbers.
    Macedo MF; Cruz E; Lacerda R; Porto G; de Sousa M
    Blood Cells Mol Dis; 2005; 35(3):319-25. PubMed ID: 16140024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
    Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
    Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis.
    Constantine CC; Anderson GJ; Vulpe CD; McLaren CE; Bahlo M; Yeap HL; Gertig DM; Osborne NJ; Bertalli NA; Beckman KB; Chen V; Matak P; McKie AT; Delatycki MB; Olynyk JK; English DR; Southey MC; Giles GG; Hopper JL; Allen KJ; Gurrin LC
    Br J Haematol; 2009 Oct; 147(1):140-9. PubMed ID: 19673882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients.
    Santos PC; Cançado RD; Pereira AC; Schettert IT; Soares RA; Pagliusi RA; Hirata RD; Hirata MH; Teixeira AC; Figueiredo MS; Chiattone CS; Krieger JE; Guerra-Shinohara EM
    Blood Cells Mol Dis; 2011 Apr; 46(4):302-7. PubMed ID: 21411349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
    Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S
    Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hemochromatosis and transferrin gene mutations on iron dyshomeostasis, liver dysfunction and on the risk of Alzheimer's disease.
    Giambattistelli F; Bucossi S; Salustri C; Panetta V; Mariani S; Siotto M; Ventriglia M; Vernieri F; Dell'acqua ML; Cassetta E; Rossini PM; Squitti R
    Neurobiol Aging; 2012 Aug; 33(8):1633-41. PubMed ID: 21514009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
    Barton JC; Wiener HW; Acton RT; Go RC
    Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
    Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
    Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
    Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
    Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic study of variation in normal mouse iron homeostasis reveals ceruloplasmin as an HFE-hemochromatosis modifier gene.
    Gouya L; Muzeau F; Robreau AM; Letteron P; Couchi E; Lyoumi S; Deybach JC; Puy H; Fleming R; Demant P; Beaumont C; Grandchamp B
    Gastroenterology; 2007 Feb; 132(2):679-86. PubMed ID: 17258727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
    Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
    Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.